Thursday, March 22, 2018 - Georgia Fogden-King
Sciad Newswire / Sciad Communications, the science, tech and health communications consultancy, is pleased to announce its corporate sponsorship of OBN, the membership organisation supporting the UK’s innovative life sciences companies.
Sciad Communications will provide PR consultancy, media liaison, marketing and social media support for OBN including its new BioForward® event; an international conference focused on creating and developing a roadmap...
Monday, February 19, 2018 - OBN
OBN are delighted to announce the launch of BioForward, a unique, high-quality, international conference, focussed on creating and developing a practical roadmap for early stage, emerging, and developing companies to achieve sustainable business success and growth.
This new, annual event will provide life science companies with the knowledge, skills, connectivity, and support necessary to maximise their chances of success, helping to ensure their...
Thursday, February 15, 2018 - Wickham Labs
Wickham Laboratories Ltd will exhibit on Stand 408 at the Making Pharmaceuticals Europe Conference, from the 13th - 14th March 2018 in Belgium at Brussels Expo centre.
Making Pharmaceutical Europe offers a free to attend exhibition and conference featuring many companies who are involved within the pharmaceutical industry.
This will be the exhibition’s inaugural event in Europe and we are proud to be supporting the expansion of the Making Pharmaceuticals...
Tuesday, January 30, 2018 - Wickham Labs
Wickham Laboratories is pleased to announce the publication of a thought leadership piece on “Rapid Testing Methods: the cost-effective safety solution” which was featured in European Pharmaceutical Review’s December 2017 issue.
In this article, Dr Lynne Murdoch discusses some of the issues companies face to get their products on the market more quickly as well as some of the challenges in transitioning from traditional methods to rapid testing...
Thursday, November 16, 2017 - Jonathan Rohll
OBN (UK) Ltd, the membership organisation that supports the life sciences industry, is delighted to announce the success of their new event BioSeed® which was held on 14th November at EY’s London offices.
BioSeed® has been designed to provide a platform for innovative life science companies to present and meet with sector specific early stage investors. The inaugural event saw 56 CEOs and decision makers present their companies to a floor of 8...
Friday, October 06, 2017 - Jonathan Rohll
OBN Awards 2017 – Winners Recognised at Industry Leading Event
Abingdon, UK, 6 October 2017: – OBN (UK) Ltd, the membership organisation that supports the life sciences industry, are delighted to announce the winners of the prestigious OBN Awards 2017 that were presented last night in front of a sold-out audience of over 250 life science industry leaders at the Town Hall in Oxford.
The Awards, which are in their...
Wednesday, July 26, 2017 - OBN
BioSeed®, a new conference created by OBN and Eurasanté, aims to showcase Europe’s most innovative early stage life sciences companies
26 July 2017, Abingdon, UK: OBN, the membership organisation supporting the UK’s innovative life sciences companies, is pleased to announce today that EY, global leader in assurance, tax, transaction and advisory services, has confirmed their support as Official Host of the first BioSeed® conference, taking place...
Thursday, April 20, 2017 - Jonathan Rohll
Abingdon, UK: OBN, the membership organisation supporting the UK’s innovative life sciences companies, announces today the appointment of Bill Fleming to its Board of Directors, effective immediately. Bill will strengthen OBN’s board and its capacity to foster innovation and growth to the sector.
Bill Fleming is Chief Financial Officer at Oxitec Limited and joined the company in 2010 from Bayer Healthcare having previously held senior finance positions...
Wednesday, February 01, 2017 - Stephen Barton
Abingdon, UK - OBN, the membership organisation supporting the UK’s innovative life sciences companies is pleased to announce today that Venner Shipley, a leading firm of European patent & trade mark attorneys and IP lawyers, has become OBN’s exclusive patent and trade mark attorney sponsor.
Through their sponsorship of OBN’s activities, thirteen best-in-class companies are now actively supporting the UK life sciences sector. Venner Shipley joins...
Thursday, January 19, 2017 - Stephen Barton
Abingdon, UK - OBN, the Membership organisation supporting the UK’s innovative life sciences companies, announced today the appointment of Mark Hooper as the new Head of Business Development with immediate effect.
Mark has over 15 years’ experience in the life sciences industry, with a thorough knowledge of the pharmaceutical drug development process, from discovery to development as well as clinical trials and commercial sales. He started work...
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, email@example.com, and we will post.